NCT05767359 2026-03-12CAR- PRISM (PRecision Intervention Smoldering Myeloma)Dana-Farber Cancer InstitutePhase 2 Active not recruiting20 enrolled
NCT05955508 2026-02-23A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple MyelomaRegeneron PharmaceuticalsPhase 2 Active not recruiting40 enrolled